| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.068 | 0.8 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |